Neo-Pancreatinum Forte (Amylase, Lipase, Protease)

Amylase, Lipase and Protease, the active ingredients in Neo-Pancreatinum Forte, are digestive enzymes presented as an oral formulation for oral use. They aid the digestion of carbohydrates, fats and proteins in patients with exocrine pancreatic insufficiency, such as those with chronic pancreatitis, cystic fibrosis or post‑surgical pancreatic loss, and improve nutritional status.

GNH USA supplies Neo-Pancreatinum Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Neo-Pancreatinum Forte provides pancreatic enzyme replacement therapy for conditions characterized by exocrine pancreatic insufficiency. - Exocrine pancreatic insufficiency: improves digestion and nutrient absorption, reducing steatorrhea and weight loss. - Chronic pancreatitis: lessens abdominal discomfort and fatty stools by supplementing deficient enzymes. - Cystic fibrosis-related pancreatic insufficiency: supports growth and maintains body weight through enhanced macronutrient breakdown.

The most frequently reported adverse reactions with Neo-Pancreatinum Forte are related to the gastrointestinal tract, while rare but serious events may occur. Common Side Effects: - Abdominal discomfort: mild pain or bloating after meals. - Flatulence: increased intestinal gas production. - Nausea: feeling of sickness without vomiting. - Diarrhea: loose stools occurring intermittently. - Constipation: reduced bowel movements. - Taste alteration: metallic or unpleasant mouthfeel. Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or hives. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe abdominal pain: persistent intense pain requiring medical attention. - Pancreatitis exacerbation: worsening of underlying pancreatic inflammation. - Eosinophilic colitis: inflammation of the colon with eosinophil infiltration.

Before initiating Neo-Pancreatinum Forte, clinicians should evaluate patient history and consider specific safety measures. - Allergy assessment: confirm no known hypersensitivity to porcine or bovine pancreatic tissue. - Medical history: review gastrointestinal disorders that may affect enzyme tolerance. - Pregnancy and lactation: use only if the potential benefit outweighs risk; consult a physician. - Concomitant medications: monitor antacids or proton‑pump inhibitors that may alter enzyme activity. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Neo-Pancreatinum Forte may interact with other medicines that modify gastric acidity or bind to enzymes. Major Interactions (Avoid): - Antacids containing aluminum or magnesium: can inactivate pancreatic enzymes. - High‑dose proton‑pump inhibitors: may require dose adjustment of the enzyme supplement. - Strong acid‑suppressive therapy: may reduce enzyme activation in the duodenum. Moderate Interactions (Monitor Closely): - Orlistat: lipase inhibition may diminish fat digestion despite supplementation. - Broad‑spectrum antibiotics: alteration of gut flora can affect enzyme efficacy. - Fiber supplements: may bind enzymes and reduce their activity.